Skip to main content

Advertisement

Table 7 Multivariate analysis of 231 cases treated at least 24 hours, odds ratio for death or other unfavourable (transfer out, default, physician's decision to stop early) outcomes.

From: Treatment outcome of extra-pulmonary tuberculosis in Finland: a cohort study

Variable Death Other unfavourable All unfavourable (death and other) together
   N OR (95% CI) p N OR (95% CI) p N OR (95% CI) p
Sex female 15 1   26 1   41 1  
  male 17 8.53 (3.23-22.50) <0.001 16 1.24 (0.55-2.84) 0.61 33 2.04 (0.98-4.24) 0.06
Age at diagnosis risk per five years   1.10 (1.06-1.14) <0.001   1.01 (0.98-1.04) 0.30   1.16 (1.03-1.31) 0.02
Immunosuppression no 22 1   38 1   60 1  
  yes 10 5.58 (1.92-16.21) 0.002 4 1.22 (0.38-3.90) 0.74 14 2.07 (1.33-3.22) 0.001
TB history no 30 1   35 1   75 1  
  yes 2 0.27 (0.05-1.59) 0.15 7 1.04 (0.44-2.43) 0.93 9 0.74 (0.32-1.70) 0.48
Site of tuberculosis superficial 13 1   26 1   39 1  
  deep 19 1.48 (0.68-3.20) 0.32 16 0.46 (0.24-0.86) 0.02 35 0.62 (0.38-1.03) 0.07
Specialty responsible for ending treatment pulmonary 8 1   34 1   42 1  
  internal medicine 7 6.85 (2.24-20.97) 0.001 5 1.09 (0.32-3.72) 0.90 12 1.89 (0.86-4.14) 0.11
  general medicine 16 28.91 (5.95-140.51) <0.001 2 0.33 (0.08-1.38) 0.13 18 2.59 (0.97-6.91) 0.06
  other 1 173.65 (12.97-2325.22) <0.001 1 1.99 (0.79-5.01) 0.14 2 5.27 (1.48-18.73) 0.01
Pause of treatment no 25 1   22 1   47 1  
  yes 7 0.25 (0.58-1.07) 0.06 20 2.48 (0.92-6.69) 0.07 27 1.28 (0.54-3.07) 0.58
Treatment group standard treatment A 18 1   17 1   35 1  
  standard treatment B 5 3.88 (0.89-16.87) 0.07 9 3.67 (1.52-8.85) 0.004 14 4.32 (2.00-9.31) <0.001
  standard treatment C 1 1.49 (0.27-8.12) 0.65 2 0.75 (0.14-4.00) 0.73 3 0.98 (0.22-4.27) 0.98
  standard treatment D 1 1.26 (0.10-16.51) 0.86 5 2.52 (0.50-12.80) 0.27 6 2.46 (0.76-8.00) 0.13
  other combination 6 5.06 (1.13-22.57) 0.03 9 1.47 (0.35-6.24) 0.60 15 2.02 (0.56-7.31) 0.28
  ineffective 1 3.44 (0.54-22.00) 0.19 0 0 <0.001 1 0.59 (0.11-3.20) 0.54
  1. Significant p-values are darkened.
  2. Reference category is favourable treatment outcome.